Montelukast Prescribing at PETROC GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,880
Total Quantity
51.9K
NHS Cost
£2.6K
vs National Avg
+174.6%
PETROC GROUP PRACTICE prescribed 1,880 items of Montelukast over the last 12 months at a cost of £2,577 to the NHS. This is 174.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
172
Jun 2026
162
Jun 2026
147
Jun 2026
160
Jun 2026
156
Jun 2026
171
Jun 2026
164
Jun 2026
172
Jun 2026
150
Jun 2026
136
Jun 2026
137
Jun 2026
153
Prescribing Details
| Total Items | 1,880 |
|---|---|
| Total Quantity | 51,858 |
| Total NHS Cost | £2,577 |
| Presentations | 4 different forms |
| vs National Average | +174.6% |
Montelukast Prescribing Comparison
| This practice | 1,880 items |
|---|---|
| National average per practice | 685 items |
| Difference | +174.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.